We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

48 hedge funds and large institutions have $161M invested in Protara Therapeutics in 2015 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

867% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 3

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

118% more funds holding

Funds holding: 22 → 48 (+26)

63% more capital invested

Capital invested by funds: $98.8M → $161M (+$62.2M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
48
Holders Change
+26
Holders Change %
+118.18%
% of All Funds
1.29%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
29
Increased
7
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$3.97M
2
BFA
BlackRock Fund Advisors
California
+$2.99M
3
State Street
State Street
Massachusetts
+$731K
4
BIT
BlackRock Institutional Trust
California
+$658K
5
BIM
BlackRock Investment Management
Delaware
+$382K

Top Sellers

Rank Fund Capital Flow
1
DPA
Devon Park Associates
-$3.79M
2
MIM
Monashee Investment Management
Massachusetts
-$1.28M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$465K
4
CS
Credit Suisse
Switzerland
-$116K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$251K +$218K +352 New
BCM
27
Bridgeway Capital Management
Texas
$211K +$183K +296 New
PPCM
28
Pillar Pacific Capital Management
California
$205K – – –
TA
29
Teachers Advisors
New York
$202K +$174K +282 New
Charles Schwab
30
Charles Schwab
California
$197K +$170K +275 New
Morgan Stanley
31
Morgan Stanley
New York
$124K +$103K +166 +2,075%
NFA
32
Nationwide Fund Advisors
Ohio
$86K +$74.2K +120 New
BA
33
BlackRock Advisors
Delaware
$81K +$70.5K +114 New
AIG
34
American International Group
New York
$80.7K +$69.9K +113 New
RFC
35
Russell Frank Company
Washington
$48K +$42.1K +68 New
SO
36
STRS Ohio
Ohio
$44K +$39K +63 New
Deutsche Bank
37
Deutsche Bank
Germany
$33K +$28.5K +46 New
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$32K +$27.8K +45 New
ARMC
39
American Research & Management Company
Massachusetts
$18K – – –
TRCT
40
Tower Research Capital (TRC)
New York
$15K +$9.9K +16 +320%
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$11.4K +$9.9K +16 New
UBS Group
42
UBS Group
Switzerland
$10K +$8.66K +14 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$8K +$7.42K +12 New
Wells Fargo
44
Wells Fargo
California
$7K +$6.19K +10 New
Invesco
45
Invesco
Georgia
$6K +$5.57K +9 New
Bank of America
46
Bank of America
North Carolina
$4K +$3.09K +5 New
Citigroup
47
Citigroup
New York
$2K +$1.86K +3 New
Barclays
48
Barclays
United Kingdom
$2K +$2.47K +4 New
HR
49
Howe & Rusling
New York
$1K +$619 +1 New
DPA
50
Devon Park Associates
– -$3.79M -8,143 Closed
1
2
3

TARA Hedge Fund Activity: Q2 2015 in Review

48 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q2 2015, worth a combined $161M — up 63% from $98.8M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TARA positions and 3 closed out — a net gain of 26 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was RA Capital Management, adding an estimated $3.97M. The largest seller was Devon Park Associates, exiting entirely with an estimated $3.79M sold.

  • 48 institutional investors held Protara Therapeutics (TARA) as of Q2 2015, up from 22 in Q1 2015.
  • Funds reported $161M of Protara Therapeutics stock for Q2 2015, up 63% quarter-over-quarter.
  • 29 funds opened new Protara Therapeutics positions in Q2 2015 and 3 closed out, a net change of +26 holders.
  • The largest Protara Therapeutics buyer in Q2 2015 was RA Capital Management, an estimated $3.97M added.
  • The largest Protara Therapeutics seller in Q2 2015 was Devon Park Associates, an estimated $3.79M sold.

Based on aggregated 13F filings for Q2 2015.